Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Lantheus

Lantheus announces plans to divest SPECT imaging business

Janesville, Wisconsin-based nuclear fusion firm Shine Technologies is the buyer, issuing an upfront cash payment under terms of the deal. 

Rite Aid closing stores bankruptcy

Rite Aid seeking buyout as it files for bankruptcy—again

For the second time in less than two years, the struggling retail pharmacy chain has filed for Chapter 11 bankruptcy protection, seeking buyers as it prepares for store closures.

Tariffs will cost Philips Healthcare up to $340M

U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates. 
 

doctor comparing the costs of different medical treatments

Hospital transparency efforts fail to curb rising imaging prices

However, health policy efforts initiated in 2021 appear to be reducing variation in imaging costs, experts contend. 

cancer screening puzzle

How tax policies impact cancer mortality rates

According to a new analysis, the relationship between the two is actually quite significant. 

healthcare surprise billing statement payment

CPT code changes relevant to radiology for 2026

“The ACR encourages its members to review them and consider how the anticipated changes may impact their practices," the college urged recently. 

Medicaid money dollar reimbursement

State lawmaker shelves proposal to expand Medicaid coverage for breast imaging

Florida Senate Bill 1578 was slated for consideration by the full legislature after unanimously passing through three committee votes. 

Thumbnail

White House releases 2026 ‘skinny budget’ calling for $33B in cuts to HHS

The proposal would cut funds to the Centers for Disease Control and Prevention and the National Institutes of Health. However, no reduction was suggested for the Food and Drug Administration.